<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19166433</PMID>
        <DateCompleted>
            <Year>2009</Year>
            <Month>04</Month>
            <Day>17</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1742-1241</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>62</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2008</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of clinical practice</Title>
                <ISOAbbreviation>Int J Clin Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1844-50</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1742-1241.2008.01923.x</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Some patients with gastro-oesophageal reflux disease (GORD) remain symptomatic despite proton pump inhibitor (PPI) treatment. There is a need to determine the most appropriate management of these patients.</AbstractText>
                <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To assess the effectiveness of esomeprazole 40 mg in GORD symptoms persisting in patients receiving a full daily dose PPI.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In this multi-centre open label study patients who had received full daily dose PPI for 8 weeks, but were still experiencing persistent GORD symptoms, were treated with esomeprazole 40 mg for 8 weeks (n = 99). The primary outcome variable was the change in the frequency of heartburn. Patient-reported outcomes were also assessed using the Reflux Disease Questionnaire (RDQ) and the GORD Impact Scale (GIS).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean frequency of heartburn was reduced by 78% from 4.4 days a week to 1 day a week at the end of the 8-week treatment period (p &lt; 0.0001). Other GORD symptoms were also significantly reduced following of treatment with esomeprazole (all p &lt; 0.0001). All RDQ dimensions and the level of symptom control as measured by the GIS also showed significant improvement at 8 weeks.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with persistent GORD symptoms despite full dose daily PPI therapy, esomeprazole 40 mg significantly improved the frequency and severity of all GORD symptoms.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jones</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Practice &amp; Primary Care, King's College London, London, UK. roger.jones@kcl.ac.uk</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patrikios</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016430">Clinical Trial</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Int J Clin Pract</MedlineTA>
            <NlmUniqueID>9712381</NlmUniqueID>
            <ISSNLinking>1368-5031</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000897">Anti-Ulcer Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D054328">Proton Pump Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>N3PA6559FT</RegistryNumber>
                <NameOfSubstance UI="D064098">Esomeprazole</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="ErratumIn">
                <RefSource>Int J Clin Pract. 2009 Jun;63(6):977</RefSource>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000897" MajorTopicYN="N">Anti-Ulcer Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064098" MajorTopicYN="N">Esomeprazole</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005764" MajorTopicYN="N">Gastroesophageal Reflux</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006356" MajorTopicYN="N">Heartburn</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D054328" MajorTopicYN="N">Proton Pump Inhibitors</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>1</Month>
                <Day>27</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>1</Month>
                <Day>27</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>4</Month>
                <Day>18</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19166433</ArticleId>
            <ArticleId IdType="pii">IJCP1923</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1742-1241.2008.01923.x</ArticleId>
            <ArticleId IdType="pmc">PMC2680259</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2000 Oct;14(10):1249-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11012468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2001 Jan;96(1):52-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11197287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2002 Mar;97(3):575-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11922549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2003 Oct 15;18(8):767-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14535869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2003 Dec;98(12):2616-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14687806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 2004 Oct;60(8):531-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15349707</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2005 Jan;100(1):11-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15654774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2005 May;54(5):710-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15831922</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2005;(2):CD003245</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15846653</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2005 Jul 15;22(2):79-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16011666</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2006 Jan;101(1):18-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16405529</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Med Res Opin. 2006 Apr;22(4):657-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16684426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2006 Sep 1;24(5):743-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16918878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Gastroenterol. 2007 Feb;42(2):157-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17327934</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2007 Jun 15;25(12):1451-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17539985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Clin Pract. 2007 Aug;61(8):1301-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17590216</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
